Clinical diagnostic criteria for liver cancer

Liver cancer is one of the most common malignant tumors. The clinical diagnostic criteria of liver cancer play a vital role in the diagnosis and treatment of the patient's condition. Experts consider that the clinical diagnostic criteria of liver cancer can only be judged after pathological examination. They refer to the clinical diagnostic criteria of liver cancer in various countries around the world and take into account the liver function conditions to formulate the clinical diagnostic criteria of liver cancer.

Liver cancer is one of the most common malignant tumors. The clinical diagnostic criteria of liver cancer play a vital role in the diagnosis and treatment of the patient's condition. Many experts consider that the clinical diagnostic criteria of liver cancer can only be judged after pathological examination. They refer to the clinical diagnostic criteria of liver cancer in various countries around the world and consider the liver function conditions, and formulate the clinical diagnostic criteria of liver cancer.

Clinical diagnostic criteria for primary liver cancer Introduction: It is not difficult to diagnose primary liver cancer with typical clinical manifestations, but it is often in the late stage of liver cancer. Therefore, for middle-aged patients with a history of liver disease, especially male patients, who have unexplained liver pain, weight loss, and progressive liver enlargement, AFP measurement and other tests mentioned above should be performed to strive for early diagnosis.

Domestic data show that the detection rate of liver cancer screening for high-risk groups (hepatitis history for more than five years, positive hepatitis B or C virus markers, and middle-aged people) is dozens of times higher than that of natural population screening. Testing AFP in high-risk groups several times a year in combination with ultrasound imaging is a basic measure for detecting early liver cancer. A sustained low-level increase in AFP but normal transaminase is often the main manifestation of subclinical liver cancer.

Patients who can exclude pregnancy, germline embryonic tumors, active liver disease and metastatic liver cancer, and have space-occupying lesions with characteristics of liver cancer in two imaging examinations or have two liver cancer markers that are positive and one imaging examination has space-occupying lesions with characteristics of liver cancer.

Patients with clinical manifestations of liver cancer and confirmed extrahepatic metastatic lesions: including bloody ascites visible to the naked eye or cancer cells found in ascites and metastatic liver cancer can be ruled out.